Viewing nowCombinationBonbody Tablet
Bazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
LitePharmTech Co., Ltd.

MFDS item code 202004086 · Approved 2020.05.29 · Insurance code 690302980
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of spinal fractures. However, efficacy for non-spinal fractures has not yet been established, so please take note of this. Osteoporosis is a condition in which bones become weak and can fracture easily, hence this medication can help in managing the risk of spinal fractures and maintaining bone health.
Take this medicine if the patient requires bazedoxifene therapy and has an inadequate intake of vitamin D. Take 1 tablet once daily, regardless of meals. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment; therefore, it should be administered with caution. Patients with hepatic impairment: Administration of this medicine is not recommended because its safety and efficacy have not been established in patients with hepatic impairment.
This medication should only be used by postmenopausal women and should not be administered to premenopausal women or women who are pregnant or breastfeeding. This medication may increase the risk of thrombosis, thus it is advisable for women with a history of thrombosis or at high risk for thrombosis to avoid use. If you are in a condition where you cannot move for a long period, such as recovery after surgery or a prolonged bed rest, this medication should be temporarily discontinued until the patient can move again. During long travels while taking this medication, it is important to regularly move to aid in blood circulation. This medication does not thicken or proliferate the endometrium, but if uterine bleeding occurs during use, you must seek medical attention. Breast cancer patients or those with a history of breast cancer should preferably not use this medication for prevention or treatment purposes. Patients with certain genetic disorders, high calcium levels, or kidney stones should also refrain from taking this medication. Patients with hypertriglyceridemia, renal or liver dysfunction, movement restrictions, or taking specific medications should use this medication with caution and according to the physician's instructions. This medication may cause drowsiness or visual disturbances, so care should be taken when driving or operating machinery. Patients at high risk of vitamin D deficiency or with insufficient calcium intake may require additional supplementation. In case of overdose, treatment should be symptom-based, especially as excessive vitamin D intake can elevate serum calcium levels and cause various symptoms, thus caution is necessary. This medication should be kept out of reach of children and should be stored sealed in its original container.
Venous thromboembolism, deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, hypersensitivity, drowsiness, facial flushing, leg cramps, dry mouth, urticaria, rash, itching, muscle cramps, peripheral edema, elevation of blood triglycerides, increase in alanine aminotransferase, increase in aspartate aminotransferase, visual impairment, blurred vision, photophobia, visual field loss, visual disturbance, dry eye syndrome, eyelid edema, eyelid spasm, eye pain, eye swelling, vomiting, gastritis, colon polyps, belching, death, fever, generalized edema, fatigue, allergic reactions, chest discomfort, leg pain, edema, facial swelling, changes in thermal sensation, malaise, asthenia, lack of efficacy, dermatitis, localized skin reactions, increased sweating, eczema, hair loss, low back pain, joint pain, muscle weakness, shoulder rotator cuff syndrome, headache, dizziness, pharyngitis, pyelonephritis, palpitations, sputum disease, cough, asthma, shortness of breath, laryngitis, pleural effusion, increased alkaline phosphatase, liver cysts, hepatocyte damage, biliary stones, weight gain, hyperlipidemia, central obesity, dysuria, abnormal urination, kidney cysts, urinary incontinence, vaginal bleeding, breast engorgement, insomnia, leukocytosis, laceration, contusion, nausea, abdominal pain, constipation, diarrhea, myalgia, fracture, retinal hemorrhage, bradycardia, sputum disease, cough, shortness of breath, laryngitis, psychiatric symptoms, altered consciousness, headache, nausea, vomiting, loss of appetite, weight loss, increased thirst, arrhythmia, increased urinary frequency, kidney stones, renal calcification, calcification in the peripheral tissues of bones, myalgia, joint pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and the temperature should be maintained between 1 to 30 degrees Celsius at room temperature. Storing it this way will help maintain the effectiveness of the medication for a longer duration.
Yellow, biconvex, rectangular film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
LitePharmTech Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
DaeHwa Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationBazedoxifene Acetate 22.6mg · Cholecalciferol Concentrate Powder 8mg
Tablet · Prescription medication · Combination
Hyouns Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.